Clinical
BSPED Endorsed Guidelines
The guidelines included on this page have been endorsed by the BSPED and reflect the Society's views on best practice for the average patient. Each patient must be considered as an individual in the context of their condition and other medication, and whilst every effort has been made to ensure the factual accuracy of the contents no liability can be accepted for any litigation, claims or complaints arising from the use of the guidelines, which is solely at the discretion of the reader.
An endorsed guideline is one that has been commissioned by the BSPED. All other guidelines listed on this site are BSPED supported guidelines.
Endocrine Guidelines
| Creation Date | Revision Date | ||
 |
Paediatric Rare Endocrine Tumours (3.15mb) | Oct 2005 | May 2012 |
|
Shared care guidelines: Use of Gonadotrophin Releasing Hormone (GnRH) Agonists 339kb) | May 2012 | Feb 2015 |
|
Shared care guidelines: Paediatric use of Recombinant Human Growth Hormone (r-hGH) (302kb) | May 2012 | Feb 2015 |
Diabetes Guidelines
| Creation Date | Revision Date | ||||
|
Diabetic Ketoacidosis (pdf) (299kb) | Nov 2009 | Aug 2012 | ||
|
DKA Calculator (pdf) (299kb) | |
DKA Flowchart (pdf) (62kb) | ||
